Neuroprotective and neuroregenerative potential of pharmacologically-induced hypothermia with D-alanine D-leucine enkephalin in brain injury

• Published in: Neural regeneration research 2018-12, Vol.13 (12), p.2029-2037
• Main Authors: Liska, M, Crowley, Marci, Tuazon, Julian, Borlongan, Cesar
• Format: Article
• Language: English
• Subjects: Analysis; Apoptosis; Body temperature; Brain injuries; Cell death; Free radicals; Health aspects; Hypertension; Hypothermia; Hypoxia; Ischemia; Ligands; Pathology; Physiology; Review; Risk factors; Stroke; stroke; traumatic brian injury; neurodegeneration; temperature management; regenerative medicine; delta opioids; metabolic suppression; cerebrovascular disease; neurovascular disease; Traumatic brain injury; Tumor necrosis factor-TNF
• ISSN: 1673-5374; 1876-7958
• DOI: 10.4103/1673-5374.241427

Neurovascular disorders, such as traumatic brain injury and stroke, persist as leading causes of death and disability - thus, the search for novel therapeutic approaches for these disorders continues. Many hurdles have hindered the translation of effective therapies for traumatic brain injury and stroke primarily because of the inherent complexity of neuropathologies and an inability of current treatment approaches to adapt to the unique cell death pathways that accompany the disorder symptoms. Indeed, developing potent treatments for brain injury that incorporate dynamic and multiple disorder-engaging therapeutic targets are likely to produce more effective outcomes than traditional drugs. The therapeutic use of hypothermia presents a promising option which may fit these criteria. While regulated temperature reduction has displayed great promise in preclinical studies of brain injury, clinical trials have been far less consistent and associated with adverse effects, especially when hypothermia is pursued via systemic cooling. Accordingly, devising better methods of inducing hypothermia may facilitate the entry of this treatment modality into the clinic. The use of the delta opioid peptide D-alanine D-leucine enkephalin (DADLE) to pharmacologically induce temperature reduction may offer a potent alternative, as DADLE displays both the ability to cause temperature reduction and to confer a broad profile of other neuroprotective and neuroregenerative processes. This review explores the prospect of DADLE-mediated hypothermia to treat neurovascular brain injuries, emphasizing the translational steps necessary for its clinical translation.